Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Confidence in your own strength?
View:
Post by fossi_2002 on Nov 02, 2023 11:48am

Confidence in your own strength?

If Ceapro is confident in both its underlying business and its pipeline, a buyback program of its own stock would be the best investment!

Proposal:
Buyback of own shares in the amount of 5% spread over 5 years.

Calculation:
78.2 mill. shares = 5% = 3.9 mill. shares
for 1 year 780000 shares x .35c = 275000$

This is only a small amount and is easily manageable for Ceapro.
Although Ceapro would only buy just over 3000 shares per trading day, the announcement is likely to be very well received by the stock market and shareholders.

- and Gilles' argument that it is better to invest in its pipeline does not hold water in this case.




Comment by Ciao on Nov 02, 2023 6:47pm
do insiders have any confidence that CEAPRO can execute any of the following? a. a commerical PGX CoQ10 in H2 2023 or even H1 2024 b. a partnership deal of any type that will result in those "milestone" payments that were talked about years ago c. revenue recovery of their base business despite SYMRISE as a direct competitor d. successuful AV trial, Y-BG trials in 2024, or other product ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities